Early markers of cardiovascular disease

Vascul Pharmacol. 2006 Nov;45(5):277-80. doi: 10.1016/j.vph.2006.08.009. Epub 2006 Aug 23.

Abstract

Vascular endothelium function plays a pivotal role in cardiovascular pre-clinical markers. Nitric oxide secreted by the vascular endothelium has a vasodilatory effect that reduces blood pressure which, in turn, prevents increases of left ventricular mass and intima-media thickness and improves left ventricular relaxation. Modern ultrasound technique allows noninvasive assessment of endothelial function and permits identification of functional alteration prior to manifestation of anatomical changes in the cardiovascular system. However, effort is needed to improve the reliability and reproducibility of ultrasound derived measure of endothelial function. This article provides an overview of challenges of clinical determination of endothelium-dependent arterial dilatation. In addition, we highlight the necessity of targeting the pediatric population in studies aimed at preventing and treating cardiovascular disease.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adolescent Health Services
  • Adult
  • Arteries / diagnostic imaging
  • Arteries / physiopathology
  • Biological Factors / metabolism
  • Biomarkers / metabolism*
  • Cardiovascular Diseases / diagnostic imaging
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / physiopathology*
  • Cardiovascular Diseases / prevention & control*
  • Child
  • Child Health Services
  • Early Diagnosis
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / physiopathology*
  • Humans
  • Nitric Oxide / metabolism
  • Ultrasonography
  • Vasodilation

Substances

  • Biological Factors
  • Biomarkers
  • endothelium-dependent hyperpolarization factor
  • Nitric Oxide